Literature DB >> 29468281

[Current guideline-oriented follow-up of small renal masses : Applied risk scores and future outlook].

V Stühler1, S Kruck1, T Todenhöfer1, A Stenzl1, J Bedke2.   

Abstract

After surgical resection of renal cell carcinoma by laparoscopic or open partial or complete nephrectomy, medical aftercare based on the current guidelines should be provided. This seems desirable, especially because one third of patients after initial curative tumor resection develop recurrence over time. In this article, the current recommendations for follow-up will be systematically presented based on the accepted German S3 guideline and the European Association of Urology (EAU) guideline. Another point of this article will be the presentation of the currently applied risk scores to predict prognosis with a focus on molecular markers. The goal is to improve the prediction of survival and to facilitate risk-adjusted aftercare.

Entities:  

Keywords:  Biomarkers; Nephrectomy; Partial kidney resection; Recurrence; Renal cell carcinoma

Mesh:

Year:  2018        PMID: 29468281     DOI: 10.1007/s00120-018-0586-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  21 in total

1.  The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma.

Authors:  Min-Han Tan; Huihua Li; Caroline Victoria Choong; Kee Seng Chia; Chee Keong Toh; Tiffany Tang; Puay Hoon Tan; Chin Fong Wong; Weber Lau; Christopher Cheng
Journal:  Cancer       Date:  2011-05-12       Impact factor: 6.860

2.  ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.

Authors:  Samira A Brooks; A Rose Brannon; Joel S Parker; Jennifer C Fisher; Oishee Sen; Michael W Kattan; A Ari Hakimi; James J Hsieh; Toni K Choueiri; Pheroze Tamboli; Jodi K Maranchie; Peter Hinds; C Ryan Miller; Matthew E Nielsen; W Kimryn Rathmell
Journal:  Eur Urol       Date:  2014-02-25       Impact factor: 20.096

3.  DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.

Authors:  Pascale Fisel; Stephan Kruck; Stefan Winter; Jens Bedke; Jörg Hennenlotter; Anne T Nies; Marcus Scharpf; Falko Fend; Arnulf Stenzl; Matthias Schwab; Elke Schaeffeler
Journal:  Clin Cancer Res       Date:  2013-07-23       Impact factor: 12.531

4.  Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.

Authors:  Sarbjinder S Sandhu; Andrew Symes; Roger A'Hern; S A Aslam Sohaib; Tim Eisen; Martin Gore; Timothy J Christmas
Journal:  BJU Int       Date:  2005-03       Impact factor: 5.588

5.  Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.

Authors:  Jens Bedke; Stephan Buse; Maria Pritsch; Stephan Macher-Goeppinger; Peter Schirmacher; Axel Haferkamp; Markus Hohenfellner
Journal:  BJU Int       Date:  2008-12-08       Impact factor: 5.588

6.  Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.

Authors:  Bradley C Leibovich; Ken-ryu Han; Matthew H T Bui; Allan J Pantuck; Frederick J Dorey; Robert A Figlin; Arie Belldegrun
Journal:  Cancer       Date:  2003-12-15       Impact factor: 6.860

7.  The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.

Authors:  Vincenzo Ficarra; Giacomo Novara; Antonio Galfano; Matteo Brunelli; Stefano Cavalleri; Guido Martignoni; Walter Artibani
Journal:  BJU Int       Date:  2008-09-08       Impact factor: 5.588

8.  Prognostic stratification of localized renal cell carcinoma by tumor size.

Authors:  Jens Bedke; Maria Pritsch; Stephan Buse; Hildegard Jakobi; Karl-Heinz Elsaesser; Sascha Pahernik; Axel Haferkamp; Markus Hohenfellner
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

9.  CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.

Authors:  Yu-Xiang Liang; Hui-Chan He; Zhao-Dong Han; Xue-Cheng Bi; Qi-Shan Dai; Yong-Kang Ye; Wei-Jun Qin; Guo-Hua Zeng; Gang Zhu; Chuan-Liang Xu; Wei-de Zhong
Journal:  Cancer Invest       Date:  2009-08       Impact factor: 2.176

Review 10.  Systemic therapy in metastatic renal cell carcinoma.

Authors:  Jens Bedke; Thomas Gauler; Viktor Grünwald; Axel Hegele; Edwin Herrmann; Stefan Hinz; Jan Janssen; Stephan Schmitz; Martin Schostak; Hans Tesch; Stefan Zastrow; Kurt Miller
Journal:  World J Urol       Date:  2016-06-09       Impact factor: 4.226

View more
  1 in total

1.  Efficacy of povidone-iodine against accidental tumor incision during nephron-sparing surgery: experimental study in patients with renal cell carcinoma.

Authors:  Gang Li; Chao Zhi; Dongsheng Zhu; Zihao Liu; Yuanjie Niu
Journal:  J Int Med Res       Date:  2019-09-18       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.